MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 29.48
-2.12 (-6.71%)
At close: Nov 10, 2025
MedinCell Market Cap
MedinCell has a market cap or net worth of €975.61 million as of November 10, 2025. Its market cap has increased by 119.22% in one year.
Market Cap
975.61M
Enterprise Value
971.03M
Revenue
27.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
€29.48
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 975.61M, an increase of 567.74%. That is a compound annual growth rate of 30.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 1.05B | 115.27% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | 225.98M | 63.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.22B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.34B |
| bioMérieux | 12.59B |
| Eurofins Scientific SE | 10.34B |
| Ipsen | 10.18B |
| ABIVAX Société Anonyme | 6.68B |
| Virbac | 2.89B |